How do I buy Pyxis Oncology, Inc. Common Stock (PYXS) stock?

Buying Pyxis Oncology, Inc. Common Stock (PYXS) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "PYXS", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy PYXS by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if PYXS is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Pyxis Oncology, Inc. Common Stock (PYXS) Stock

Q: What is the minimum investment for PYXS on Gotrade?

On Gotrade , you don't have to buy a full lot. With fractional shares, you can start investing in Pyxis Oncology, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · PYXS

Trade PYXS

Key stats

Market cap: $149.30M
Price / Earnings ratio: -1.7x
EPS (TTM): -$1.41
Volume: Loading
52-week high: $5.55
52-week low: $1.03

Source: third-party data provider, as of October 16, 2026

Compare with PYXS

Technical indicators

RSI 14: 26.21
MACD 12/26/9: -0.36
EMA 9 of MACD: -0.29
MACD histogram: -0.07
SMA 50: $3.01; Price below SMA 50
EMA 50: $2.71; Price below EMA 50
SMA 200: $2.14; Price below SMA 200
EMA 200: $2.58; Price below EMA 200

Calculated by Gotrade from daily closing prices, as of October 14, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 3 analyst ratings

Strong Sell0

Sell0

Hold0

Buy3

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2025

17M11M5M0

Debt & Balance Sheet

Total assets

Total liabilities

2025

110M72M36M0

Revenue to Profit

2025

$13.9M

Revenue

$0.0

Cost of revenue

$11.5M

Gross profit

$0.0

Operating expenses

$-79.6M

Net income

Earnings

No data available

Source: third-party data provider

About Pyxis Oncology, Inc. Common Stock

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

SectorHealthcare

IndustryBiotechnology

Employees56

CEOMr. Thomas Civik

IPO DateOct 6, 2021

HeadquartersBoston, MA

Key Executives

Name	Title	Year Born
Mr. Thomas Civik	Interim CEO & Director	1969
Mr. Jitendra Wadhane C.A., CPA	Chief Accounting Officer, Senior VP of Finance, Corporate Controller & Principal Financial Officer	1981
Dr. Balu N. Balasubramanian Ph.D.	Interim Chief Technology Officer	—
Donna Regalado	Head of Human Resources	—
Dr. Charles T. Gombar Ph.D.	Senior Vice President of Portfolio & Program Management	—
Dr. Michael Bui	Senior Vice President of Global Regulatory Affairs	—
Dr. Supriya Roth Ph.D.	Head of Commercial Development	—
Dr. Shui He Ph.D.	Head of Biometrics	—
Dr. Hongwei Wang M.D., Ph.D.	Head of ADC Development & Clinical Strategy	—
Dr. Marsha Crochiere Ph.D.	Head of Translational Medicine & Research	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021										+15.0	-3.3	-10.7
2022	-16.5	-36.2	-22.8	-31.4	-3.1	-0.4	+8.6	+0.0	-25.1	-6.5	-14.2	-7.6
2023	+13.0	+39.3	+65.7	-27.5	+11.4	-22.7	-2.6	-15.2	-14.2	-18.5	-8.1	+10.4
2024	+85.0	+71.4	-35.4	-7.1	-15.0	-12.0	+22.5	+2.7	+6.7	+1.4	-46.5	-22.0
2025	-7.1	-20.7	-11.7	+19.6	+10.0	-9.8	+3.7	+16.4	+66.9	+62.6	+36.2	-73.8
2026	+26.1	-3.9	-0.7	+15.6	+4.7	+68.2	-7.0	+6.6	-32.3	-18.3

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

FAQ

Buying Pyxis Oncology, Inc. Common Stock (PYXS) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and complete KYC.
Make a deposit.
Search for the code "PYXS", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy PYXS by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Pyxis Oncology, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Pyxis Oncology, Inc. Common Stock (PYXS) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track PYXS's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB, or 8:30 PM to 3:00 AM WIB during Daylight Saving Time. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.

Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Pyxis Oncology, Inc. Common Stock (PYXS) Stock

Key stats

Compare with PYXS

Recent news

3 Biotech Stocks to Buy on the Dip: March 2024

3 Biotech Stocks to Buy on the Dip: March 2024

From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires

From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires

Why Am I Losing Money With Penny Stocks? 3 Reasons

Why Am I Losing Money With Penny Stocks? 3 Reasons

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

3 Biotech Stocks to Buy on the Dip: March 2024

3 Biotech Stocks to Buy on the Dip: March 2024

From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires

From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires

Why Am I Losing Money With Penny Stocks? 3 Reasons

Why Am I Losing Money With Penny Stocks? 3 Reasons

About Pyxis Oncology, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade